Bioanalysis of Cannabinoids

An LC-MS team specializing in tailored assays for precise cannabinoid PK measurements.

Cannabinoids are a class of compounds that have been utilized extensively due to the breadth of their therapeutic potential.

Resolian’s LC-MS team provides significant expertise in the development and validation of bespoke LC-MS assays to measure the pharmacokinetics (PK) of cannabinoids from early-stage pre-clinical dog, rat and mouse studies up to regulated GCP studies.

The team’s experience of the CBD and THC molecules and their metabolites covers numerous matrices – some assays include up to 8 analytes in a single analysis with sensitivity down to 0.125 ng/mL.

In addition to these, Resolian has developed and validated a variety of proprietary methods across a broad range of species and matrices.

Reach out to us directly to learn more about Resolian’s Bioanalysis of Cannabinoids services.

Our
Resources

Our Resources

Globally Harmonized Labs

ELISpot-Antigen Specific Response Assays

Biomarker Assay List

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.